絞り込み

16525

広告

A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder.

著者 Hobart M , Skuban A , Zhang P , Augustine C , Brewer C , Hefting N , Sanchez R , McQuade RD
J Clin Psychiatry.2018 May 22 ; 79(4):.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (3view , 0users)

Full Text Sources

Medical

To assess the efficacy, safety, and tolerability of brexpiprazole as adjunct to antidepressant treatment (ADT) in adults with major depressive disorder (MDD) and inadequate response to ADTs.
PMID: 29873953 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード